Not Tagged
Not Tagged
['crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
phase ii trial of anti-psma mab j591 labelling w/ 177lu vs 111in in nmcrpc 18-mo mfs (1 outcome): 50% w/ 177lu vs 24% with 111in psa50: 82 vs 71% psa90: 50 vs 35% heme toxicity with 177lu (neutropenia 57 vs 11%; thrombocytopenia 77 vs 11%)
#gu23 
MD, MSc | @UofTUrology @SUO_YUO Fellow & @IHPMEUofT CEHCR PhD| Previously: @AUB_Lebanon and @MCG_Urology